| [1] |
Wernberg JA, Lucarelli DD. Gallbladder cancer[J]. Surg Clin North Am, 2014, 94(2):343-360.
|
| [2] |
Kwon YJ, Lee KG. Is T-stage the only significant factor determining the extent of surgery for gallbladder cancer?[J]. Hepatogastroenterology, 2014, 61(130):304-306.
|
| [3] |
Piccolo G, Di Vita M, Cavallaro A, et al. Lymph node evaluation in gallbladder cancer: which role in the prognostic and therapeutic aspects. update of the literature[J]. Eur Rev Med Pharmacol Sci, 2014, 18(2 Suppl):47-53.
|
| [4] |
Are C. Common controversies in the management of gallbladder cancer[J]. J Natl Compr Canc Netw, 2014, 12(5 Suppl):833-835.
|
| [5] |
Rakic M, Patrlj L, Kopljar M, et al. Gallbladder cancer[J]. Hepatobiliary Surg Nutr, 2014, 3(5):221-226.
|
| [6] |
Lee SE, Kim KS, Kim WB, et al. Practical guidelines for the surgical treatment of gallbladder cancer[J]. J Korean Med Sci, 2014, 29(10):1333-1340.
|
| [7] |
Garg PK, Pandey D, Sachdeva S. Preventive cholecystectomy for gallbladder cancer in high-risk groups: primary or secondary prevention[J]. Eur J Gastroenterol Hepatol, 2014, 26(12):1439.
|
| [8] |
Kai K, Aishima S, Miyazaki K. Gallbladder cancer: clinical and pathological approach[J]. World J Clin Cases, 2014, 2(10):515-521.
|
| [9] |
Downing SR, Cadogan KA, Ortega G, et al. Early-stage gallbladder cancer in the surveillance, epidemiology, and end results database: effect of extended surgical resection[J]. Arch Surg, 2011, 146(6):734-738.
|
| [10] |
Pawlik TM, Gleisner AL, Vigano L, et al. Incidence of finding residual disease for incidental gallbladder carcinoma: implications for re-resection[J]. J Gastrointest Surg, 2007, 11(11):1478-1487.
|
| [11] |
Agarwal AK, Kalayarasan R, Javed A, et al. The role of staging laparoscopy in primary gall bladder cancer: an analysis of 409 patients: a prospective study to evaluate the role of staging laparoscopy in the management of gallbladder cancer[J]. Ann Surg, 2013, 258(2):318-323.
|
| [12] |
Butte JM, Gonen M, Allen PJ, et al. The role of laparoscopic staging in patients with incidental gallbladder cancer[J]. HPB, 2011, 13(7):463-472.
|
| [13] |
Regimbeau JM, Fuks D, Bachellier P, et al. Prognostic value of jaundice in patients with gallbladder cancer by the AFC-GBC-2009 study group[J]. Eur J Surg Oncol, 2011, 37(6):505-512.
|
| [14] |
Fuks D, Regimbeau JM, Pessaux P, et al. Is port-site resection necessary in the surgical management of gallbladder cancer?[J]. J Visc Surg, 2013, 150(4):277-284.
|
| [15] |
Maplanka C. Gallbladder cancer, treatment failure and relapses: the peritoneum in gallbladder cancer[J]. J Gastrointest Cancer, 2014, 45(3):245-255.
|
| [16] |
Dingle BH, Rumble RB, Brouwers MC. The role of gemcitabine in the treatment of cholangiocarcinoma and gallbladder cancer: a systematic review[J]. Can J Gastroenterol, 2005, 19(12):711-716.
|
| [17] |
Hezel AF, Noel MS, Allen JN, et al. PhaseⅡ study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancer[J]. Br J Cancer, 2014, 111(3):430-436.
|
| [18] |
Dutta U. Gallbladder cancer: can newer insights improve the outcome?[J]. J Gastroenterol Hepatol, 2012, 27(4):642-653.
|
| [19] |
Einama T, Uchida K, Taniguchi M, et al. Successful curative resection of gallbladder cancer following S-1 chemotherapy: a case report and review of the literature[J]. Oncol Lett, 2014, 8(6):2443-2447.
|
| [20] |
王健东，全志伟．胆囊癌的综合治疗[J]．中华消化外科杂志，2011, 10(2):93-95.
|
| [21] |
Jeong Y, Park JH, Lee YJ, et al. Postoperative radiotherapy for gallbladder cancer[J]. Anticancer Res, 2014, 34(10):5621-5629.
|
| [22] |
Nakagawara H, Tajima H, Miyashita T, et al. Lymph node spread of gallbladder cancer from the perspective of embryologically-based anatomy and significance of the lymphatic basin along the embryonic right hepatic artery[J]. Mol Clin Oncol, 2014, 2(6):963-967.
|
| [23] |
Hyder O, Dodson RM, Sachs T, et al. Impact of adjuvant external beam radiotherapy on survival in surgically resected gallbladder adenocarcinoma: a propensity score-matched surveillance, epidemiology, and end results analysis[J]. Surgery, 2014, 155(1):85-93.
|
| [24] |
Kim K, Chie EK, Jang JY, et al. Postoperative chemoradiotherapy for gallbladder cancer[J]. Strahlenther Onkol, 2012, 188(5):388-392.
|
| [25] |
Caldow PC, Groeschl RT, Quebbeman EJ, et al. Recent advances in systemic therapies and radiotherapy for gallbladder cancer[J]. Surg Oncol, 2013, 22(1):61-67.
|
| [26] |
Rungsakulkij N, Boonsakan P. Synchronous gallbladder and pancreatic cancer associated with pancreaticobiliary maljunction[J]. World J Gastroenterol, 2014, 20(39):14500-14504.
|
| [27] |
Kalayarasan R, Javed A, Puri AS, et al. A prospective analysis of the preoperative assessment of duodenal involvement in gallbladder cancer[J]. HPB, 2013, 15(3):203-209.
|
| [28] |
Hijioka S, Mekky MA, Bhatia V, et al. Can EUS-guided FNA distinguish between gallbladder cancer and xanthogranulomatous cholecystitis?[J]. Gastrointest Endosc, 2010, 72(3):622-627.
|
| [29] |
Akiyama T, Hasegawa T, Sejima T, et al. Anomalous junction of the pancreaticobiliary duct accompanied by gallbladder cancer and obstructive jaundice in a patient with high serum and bile cytokine levels[J]. J Gastroenterol, 1998, 33(4):597-601.
|
| [30] |
Qin Y, Chu B, Gong W, et al. Inhibitory effects of deleted in liver cancer 1 gene on gallbladder cancer growth through induction of cell cycle arrest and apoptosis[J]. J Gastroenterol Hepatol, 2014, 29(5):964-972.
|
| [31] |
Zhang LQ, Zhang XD, Xu J, et al. Potential therapeutic targets for the primary gallbladder carcinoma: estrogen receptors[J]. Asian Pac J Cancer Prev, 2013, 14(4):2185-2190.
|